Health Industry

"Health Industry" Main

Latest Morning Briefing Stories

CBO: Killing Cost-Sharing Subsidies Would Hike Silver Plan Premiums And Deficit

KFF Health News Original

The change would not be expected to have much long-term effect on the number of uninsured people. But it could cause a shift in which plans are popular with marketplace customers.

Podcast: ‘What The Health?’ No Vacation For Insurers

KFF Health News Original

In this episode of “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Sarah Kliff of Vox.com, and Margot Sanger-Katz of The New York Times discuss the state of the individual health insurance markets in the wake of the failure (for now) of Congress’s efforts to repeal and replace the Affordable Care Act.

Senate Democrats Delay HHS Nominee Over Women’s Health Funding

KFF Health News Original

Sen. Patty Murray questions Dr. Brett Giroir’s willingness to stand up for women’s health programs such as family planning services and teenage pregnancy prevention.

Florida Law Will Let Patients Get All Their Drug Renewals At The Same Time

KFF Health News Original

The new law will help people with chronic conditions that require multiple prescriptions cut down on their shuttles to the drug store and could improve adherence to their drugs.

Despite Insurers’ Tactical Win On ACA’s Cost-Sharing Payments, Uncertainty Lingers

KFF Health News Original

Court allows state attorneys general to join a pending legal challenge to keep billions in subsidies flowing to consumers and insurers, despite the Trump administration’s resistance.

Covered California Expects 12.5% Average Rate Rise In 2018

KFF Health News Original

The figure could be higher if President Trump ends an important consumer subsidy, which he has threatened to do. The exchange also announced that Anthem Blue Cross will pull out of Covered California and the overall individual market in 16 of the 19 regions it currently serves.

Denial, Appeal, Approval … An Adult’s Thorny Path To Spinraza Coverage

KFF Health News Original

The FDA granted approval for Spinraza in late December for use on children and adults with spinal muscular atrophy. Insurance coverage is mostly focused on infants and children.

Drug Puts A $750,000 ‘Price Tag On Life’

KFF Health News Original

The high cost of Spinraza, a new and promising treatment for spinal muscular atrophy, highlights how the cost-benefit analysis insurers use to make drug coverage decisions plays out in human terms.

Scope Maker Olympus Hit With $6.6 Million Verdict In Superbug Outbreak Case

KFF Health News Original

In the first case of its kind in the U.S., the company was ordered to pay damages to the hospital where a patient died of an infection linked to a contaminated scope. But jurors also found the hospital negligent, and it was ordered to pay the patients’ family $1 million.

Over-The-Counter Devices Hold Their Own Against Costly Hearing Aids

KFF Health News Original

In a head-to-head comparison, several of the cheaper devices performed nearly as well as the expensive hearing aids. The study lends credence to lawmakers’ efforts to get the FDA to set standards for over-the-counter versions.

In Appalachia, Two Hospital Giants Seek State-Sanctioned Monopoly

KFF Health News Original

Tennessee and Virginia regulators are considering approval of a merger between Mountain States Health Alliance and Wellmont Health System under their state laws. If they allow it, the Federal Trade Commission would be powerless to stop it.